Search by Drug Name or NDC

NDC 68788-7603-03 Carvedilol 6.25 mg/1 Details

Carvedilol 6.25 mg/1

Carvedilol is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is CARVEDILOL.

MedlinePlus Drug Summary

Carvedilol is used to treat heart failure (condition in which the heart cannot pump enough blood to all parts of the body) and high blood pressure. It also is used to treat people who have had a heart attack. Carvedilol is often used in combination with other medications. Carvedilol is in a class of medications called beta-blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 68788-7603-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Carvedilol

Product Information

NDC	68788-7603
Product ID	68788-7603_821557a6-b35d-4f15-be4c-014e7d21b8bd
Associated GPIs	33300007000310
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Carvedilol
Proprietary Name Suffix	n/a
Non-Proprietary Name	Carvedilol
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	6.25
Active Ingredient Units	mg/1
Substance Name	CARVEDILOL
Labeler Name	Preferred Pharmaceuticals Inc.
Pharmaceutical Class	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA078251
Listing Certified Through	2024-12-31

Package

NDC 68788-7603-03 (68788760303)

Pricing Information	N/A
NDC Package Code	68788-7603-3
Billing NDC	68788760303
Package	30 TABLET, FILM COATED in 1 BOTTLE (68788-7603-3)
Marketing Start Date	2020-02-07
NDC Exclude Flag	N